• 1
    Avis NE, Zhao X, Johannes CB et al. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women’s Health Across the Nation (SWAN). Menopause 2005; 2: 38598
  • 2
    Safarinejad MR. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors. Int J Impot Res 2006; 18: 38295
  • 3
    Graziottin A. Prevalence and evaluation of sexual health problems – HSDD in Europe. J Sex Med 2007; 4: 2119
  • 4
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text rev. Washington, DC: American Psychiatric Association, 2000
  • 5
    Modell JG, Katholi CR, Modell JD et al. Comparative sexual side effects of SSRIs and bupropion. Clin Pharmacol Ther 1997; 61: 47687
  • 6
    Haavio-Mannila E, Kontula O. Correlates of increased sexual satisfaction. Arch Sex Behav 1997; 26: 399419
  • 7
    McCabe MP. Intimacy and quality of life among sexually dysfunctional men and women. J Sex Marital Ther 1997; 23: 27690
  • 8
    Laumann EO, Paik A, Rosen RD. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 53744
  • 9
    Safarinejad MR. Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study. J Sex Med 2008; 5: 88797
  • 10
    Kingsberg S, Shifren J, Wekselman K et al. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med 2007; 4: 10018
  • 11
    Schover LR. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk? Fertil Steril 2008; 90: 12940
  • 12
    Altwein JE, Keuler FU. Oral treatment of erectile dysfunction with apomorphine SL. Urol Int 2001; 67: 25763
  • 13
    Cannas A, Solla P, Floris G et al. Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: a rare case of iatrogenic paraphilia. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 153941
  • 14
    Caruso S, Agnello C, Intelisano G et al. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology 2004; 63: 9559
  • 15
    Papakostas GI, Nutt DJ, Hallett LA et al. Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry 2006; 60: 13505
  • 16
    Segraves RT, Croft H, Kavoussi R et al. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women. J Sex Marital Ther 2001; 27: 30316
  • 17
    Clayton AH, Warnock JK, Kornstein SG et al. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004; 65: 627
  • 18
    Segraves RT, Clayton A, Croft H et al. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004; 24: 33942
  • 19
    Basson R, Berman J, Burnett A et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 88893
  • 20
    Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav 1994; 23: 62743
  • 21
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994
  • 22
    Bernstein-Carlson E, Putnam FW. An update on the Disssociative Experiences Scale. Dissociation 1993; 6: 1627
  • 23
    Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1956; 32: 505
  • 24
    Heimberg RG, Horner KJ, Juster HR et al. Psychometric properties of the Liebowitz Social Anxiety Scale. Psychol Med 1999; 29: 199212
  • 25
    Heyman RE, Smith Slep AM, Beach SR et al. Relationship problems and the DSM: needed improvements and suggested solutions. World Psychiatry 2009; 8: 714
  • 26
    Mazer NA, Leiblum SR, Rosen RC. The brief index of sexual functioning for women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal populations. Menopause 2000; 7: 35063
  • 27
    Derogatis L, Rust J, Golombok S et al. A patient generated, multinational inventory to measure distress associated with low desire. Paper presented at the annual meeting of the International Society for the Study of Women’s Sexual Health, Atlanta, Ga; October 30, 2004
  • 28
    Simon J, Braunstein G, Nachtigall L et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005; 90: 522633
  • 29
    Dennerstein L, Koochaki P, Barton I et al. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med 2006; 3: 21222
  • 30
    Guay AT. Decreased testosterone in regularly menstruating women with decreased libido: a clinical observation. J Sex Marital Ther 2001; 27: 5139
  • 31
    Guay AT, Jacobson J. Decreased free testosterone and dehydroepiandrosterone-sulfate (DHEA-S) levels in women with decreased libido. J Sex Marital Ther 2002; 28 (Suppl. 1): 12942
  • 32
    Mathias C, Cardeal Mendes CM, Pondé de Sena E et al. An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer. Ann Oncol 2006; 17: 17926
  • 33
    Safarinejad MR. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study. J Psychopharmacol 2010; doi:10.1177/0269881109351966
  • 34
    López HH, Wurzel G, Ragen B. The effect of acute bupropion on sexual motivation and behavior in the female rat. Pharmacol Biochem Behav 2007; 87: 36979
  • 35
    Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000; 57: 101230
  • 36
    Driver-Dunckley ED, Noble BN, Hentz JG et al. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 2007; 30: 24955
  • 37
    Regan P, Berscheid I. Belief about the state, goals and objects of sexual desire. J Sex Marit Ther 2004; 22: 11020
  • 38
    Wilens TE, Prince JB, Spencer T et al. An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. Biol Psychiatry 2003; 54: 916
  • 39
    Shoptaw S, Heinzerling KG, Rotheram-Fuller E et al. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend 2008; 96: 22232